Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
U

Ultimovacs ASA
F:7UM

Watchlist Manager
Ultimovacs ASA
F:7UM
Watchlist
Price: 1.066 EUR -0.93% Market Closed
Market Cap: €36.7m
Write Note Create Alert Ask AI

Ultimovacs ASA
Investor Relations

Ultimovacs AS operates as a pharmaceutical company. The company is headquartered in Oslo, Oslo. The company went IPO on 2019-06-03. The firm's lead product candidate is UV1, a peptide-based vaccine inducing a specific T cell response against the universal cancer antigen telomerase. UV1 is being developed as a therapeutic cancer vaccine which may serve as a platform for use in combination with other immuno-oncology drugs which require an ongoing T cell response for their mode of action. The firm is performing a broad clinical development program with clinical trials in Europe and the USA.

Show more
Loading
7UM
DAX Index
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q4 2024
Call Date
Jan 31, 2025
Q4 2024 Earnings Call
No Analysis Available

This earnings call has not been analyzed yet.

If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.

Request Earnings Call Analysis
Earnings Call Recording
Open Transcript
Other Earnings Calls

Management

Dr. Carlos de Sousa
Chief Executive Officer
No Bio Available
Mr. Hans Vassgard Eid
Chief Financial Officer
No Bio Available
Ms. Ingunn Hagen Westgaard Ph.D.
Head of Research
No Bio Available
Mr. Audun Tornes
Chief Technology Officer
No Bio Available
Mr. Jens Egil Torbjorn Bjorheim M.D., Ph.D.
Chief Medical Officer
No Bio Available
Mr. Oivind Foss Ph.D.
Head of Clinical Operations
No Bio Available
Orla Mc Callion
Head of Regulatory Affairs & QA
No Bio Available
Torill Trones
Head of Office
No Bio Available

Contacts

Address
OSLO
Oslo
Ullernchausseen 64
Contacts
+4741380080.0
ultimovacs.com
sparklesyt

See Also

Summary
7UM intrinsic value, competitors valuation, and company profile.
DCF Valuation
7UM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
7UM stock valuation using valuation multiples.
Wall Street Estimates
7UM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
7UM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 314,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.